Total Payments
$19,760
2024 Payments
$2,790
Companies
62
Transactions
1,409
Medicare Patients
4,440
Medicare Billing
$794,082
Payment Breakdown by Category
Food & Beverage$19,738 (99.9%)
Education$21.78 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,738 | 1,396 | 99.9% |
| Education | $21.78 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,663 | 180 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,582 | 146 | $0 (2024) |
| Lilly USA, LLC | $1,845 | 151 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,521 | 111 | $0 (2024) |
| Novo Nordisk Inc | $1,455 | 124 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,322 | 102 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $631.98 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $620.91 | 49 | $0 (2023) |
| PFIZER INC. | $560.85 | 46 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $517.86 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,790 | 151 | AstraZeneca Pharmaceuticals LP ($635.78) |
| 2023 | $3,008 | 195 | GlaxoSmithKline, LLC. ($523.79) |
| 2022 | $2,380 | 175 | AstraZeneca Pharmaceuticals LP ($321.25) |
| 2021 | $2,397 | 162 | GlaxoSmithKline, LLC. ($610.55) |
| 2020 | $1,248 | 91 | AstraZeneca Pharmaceuticals LP ($291.53) |
| 2019 | $2,188 | 186 | GlaxoSmithKline, LLC. ($285.27) |
| 2018 | $2,494 | 208 | Merck Sharp & Dohme Corporation ($256.84) |
| 2017 | $3,255 | 241 | Lilly USA, LLC ($435.76) |
All Payment Transactions
1,409 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.31 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,050 | 3,019 | $488,412 | $215,198 |
| 2022 | 24 | 1,079 | 2,660 | $398,449 | $144,565 |
| 2021 | 23 | 1,126 | 3,110 | $475,253 | $221,126 |
| 2020 | 25 | 1,185 | 3,317 | $453,244 | $213,193 |
Total Patients
4,440
Total Services
12,106
Medicare Billing
$794,082
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 1,037 | $129,625 | $70,078 | 54.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 259 | 692 | $172,658 | $66,467 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 226 | 464 | $93,043 | $31,655 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $19,154 | $10,949 | 57.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 21 | 180 | $14,400 | $7,316 | 50.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 49 | $11,025 | $5,370 | 48.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 117 | $11,700 | $5,056 | 43.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 49 | 57 | $8,550 | $3,328 | 38.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 25 | 30 | $6,740 | $2,976 | 44.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 33 | 37 | $4,625 | $2,574 | 55.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 72 | $3,258 | $2,446 | 75.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 63 | 63 | $2,520 | $2,110 | 83.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $2,400 | $1,570 | 65.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 13 | $2,275 | $1,281 | 56.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $1,650 | $621.59 | 37.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 53 | 54 | $2,823 | $540.12 | 19.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 38 | $1,360 | $453.60 | 33.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $606.00 | $407.64 | 67.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 551 | $131,726 | $36,909 | 28.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 550 | $68,750 | $33,468 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 213 | 398 | $77,988 | $20,341 | 26.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 32 | 266 | $21,280 | $11,918 | 56.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 23 | 164 | $16,400 | $8,653 | 52.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $17,650 | $6,117 | 34.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 66 | 79 | $11,850 | $5,044 | 42.6% |
About Dr. Pranay Bhatt, M.D
Dr. Pranay Bhatt, M.D is a Internal Medicine healthcare provider based in Bloomfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952381287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pranay Bhatt, M.D has received a total of $19,760 in payments from pharmaceutical and medical device companies, with $2,790 received in 2024. These payments were reported across 1,409 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($19,738).
As a Medicare-enrolled provider, Bhatt has provided services to 4,440 Medicare beneficiaries, totaling 12,106 services with total Medicare billing of $794,082. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bloomfield, NJ
- Active Since 01/20/2006
- Last Updated 04/16/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952381287
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,783
- FARXIGA (Drug) $1,535
- JARDIANCE (Drug) $1,157
- BREZTRI (Drug) $699.92
- JANUVIA (Drug) $648.07
- TRULICITY (Drug) $637.15
- Ozempic (Drug) $610.08
- ENTRESTO (Drug) $548.30
- MOUNJARO (Drug) $473.52
- Vascepa (Drug) $455.21
- ELIQUIS (Drug) $446.66
- XARELTO (Drug) $439.09
- AREXVY (Drug) $315.16
- AFREZZA (Drug) $303.40
- Livalo (Drug) $299.56
- BELSOMRA (Drug) $288.50
- XIFAXAN (Drug) $281.93
- Victoza (Drug) $277.40
- FREESTYLE LIBRE 3 (Device) $239.49
- Kerendia (Drug) $239.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomfield
Bechara Barrak, Md, MD
Internal Medicine — Payments: $38,899
Internal Medicine $38,899
John Wenceslao, Md, MD
Internal Medicine — Payments: $36,810
Internal Medicine $36,810
Dr. Roy Kellerman, Md, MD
Internal Medicine — Payments: $17,119
Internal Medicine $17,119
Sheila Silverman, Md, MD
Internal Medicine — Payments: $10,559
Internal Medicine $10,559
John Kelly, Md, MD
Internal Medicine — Payments: $8,306
Internal Medicine $8,306
Edwin Fierer, Md, MD
Internal Medicine — Payments: $8,160
Internal Medicine $8,160